- Home
- NGS vs CADL Comparison
NGS vs CADL Comparison
Compare NGS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- CADL
- Stock Information
- Founded
- NGS 1998
- CADL 1999
- Country
- NGS United States
- CADL United States
- Employees
- NGS N/A
- CADL N/A
- Industry
- NGS Oilfield Services/Equipment
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- CADL Health Care
- Exchange
- NGS Nasdaq
- CADL Nasdaq
- Market Cap
- NGS N/A
- CADL 234.8M
- IPO Year
- NGS 2002
- CADL 2021
- Fundamental
- Price
- NGS $20.11
- CADL $4.76
- Analyst Decision
- NGS Strong Buy
- CADL Strong Buy
- Analyst Count
- NGS 1
- CADL 4
- Target Price
- NGS $32.00
- CADL $21.00
- AVG Volume (30 Days)
- NGS 71.1K
- CADL 864.6K
- Earning Date
- NGS 05-12-2025
- CADL 05-13-2025
- Dividend Yield
- NGS N/A
- CADL N/A
- EPS Growth
- NGS 260.53
- CADL N/A
- EPS
- NGS 1.37
- CADL N/A
- Revenue
- NGS $156,742,000.00
- CADL N/A
- Revenue This Year
- NGS $12.87
- CADL N/A
- Revenue Next Year
- NGS $15.40
- CADL N/A
- P/E Ratio
- NGS $14.68
- CADL N/A
- Revenue Growth
- NGS 29.36
- CADL N/A
- 52 Week Low
- NGS $16.70
- CADL $3.79
- 52 Week High
- NGS $29.74
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- NGS 53.74
- CADL 41.42
- Support Level
- NGS $17.63
- CADL $4.80
- Resistance Level
- NGS $19.68
- CADL $5.34
- Average True Range (ATR)
- NGS 1.00
- CADL 0.33
- MACD
- NGS 0.28
- CADL 0.10
- Stochastic Oscillator
- NGS 90.51
- CADL 42.09
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.